Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial-Reference-Cited by-同舟云学术

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial

Published:2015-11-13 Issue:3 Volume:20 Page:421-431
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Pun Patrick H.¹,Abdalla Safa²,Block Geoffrey A.³,Chertow Glenn M.²,Correa-Rotter Ricardo⁴,Dehmel Bastian⁵,Drüeke Tilman B.⁶,Floege Jürgen⁷,Goodman William G.⁵,Herzog Charles A.⁸,London Gerard M.⁹¹⁰,Mahaffey Kenneth W.²,Moe Sharon M.⁹¹⁰,Parfrey Patrick S.¹¹,Wheeler David C.¹²,Middleton John P.¹

Affiliation:

1. Department of Medicine; Duke University; Durham North Carolina USA

2. Department of Medicine; Stanford University School of Medicine; Palo Alto California USA

3. Denver Nephrology; Denver Colorado USA

4. Nephrology and Mineral Metabolism; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; Mexico City District Federal Mexico

5. Amgen, Inc; Thousand Oaks California USA

6. Inserm Unit 1088; UFR Médecine/Pharmacie, Université de Picardie; Amiens France

7. Department of Nephrology; Universitätsklinikum der RWTH Aachen; Aachen Germany

8. University of Minnesota; Minneapolis Minnesota USA

9. Hôpital Manhès; Paris France

10. Indiana University School of Medicine and Roudebush Veterans Administration Medical Center; Indianapolis Indiana USA

11. Health Sciences Center; St. John's Newfoundland Canada

12. University College London; London United Kingdom

Funder

Amgen

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12382/fullpdf

Reference19 articles.

1. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO);Herzog;Kidney Int,2011

2. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

3. Impact of serum parathyroid hormone concentration and its regulatory factors on arterial stiffness in patients undergoing maintenance hemodialysis;Suzuki;Blood Purif,2004

4. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia;London;Curr Opin Nephrol Hypertens,2005

5. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients;Sande;Am J Kidney Dis,1998

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between calcium administration and outcomes during adult cardiopulmonary resuscitation at the emergency department;Turkish Journal of Emergency Medicine;2022

2. Sudden Cardiac Death in End Stage Kidney Disease: Technologies for Determining Causes and Predicting Risk;Technological Advances in Care of Patients with Kidney Diseases;2022

3. Skeletal and cardiovascular consequences of a positive calcium balance during hemodialysis;Brazilian Journal of Nephrology;2021-12

4. Prolongation of QTc interval at the beginning and during dialysis is associated with hypervolemia and calcium and magnesium change in the first 2 h;International Urology and Nephrology;2021-10-19

5. Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy;International Journal of Endocrinology;2021-04-02